Speaker(s): 

Alyson Floyd, MS, CGC, Genetic Counselor II, Geisinger (has nothing to disclose)

Kelly Morgan, MS, CGC, Genetic Counselor Senior, Geisinger (has nothing to disclose)

Caroline deRichemond, CRNP, CLS, FNLA, Nurse Practitioner Cardiology, Geisinger (has nothing to disclose)

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Discuss clinical presentation and management of patients with FH

• Examine case examples from the MyCode GSC cohort

• Review FH-targeted research initiatives

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None